William Blair & Company’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.52K Hold
3,092
﹤0.01% 1834
2025
Q4
$10.8K Sell
3,092
-4
-0.1% -$27 ﹤0.01% 1778
2025
Q3
$27.7K Buy
3,096
+666
+27% +$5.02K ﹤0.01% 1693
2025
Q2
$15.3K Buy
+2,430
New +$19K ﹤0.01% 1701
2025
Q1
Sell
-2,517
Closed -$28.3K 1866
2024
Q4
$28.3K Hold
2,517
﹤0.01% 1664
2024
Q3
$48.6K Hold
2,517
﹤0.01% 1635
2024
Q2
$56.7K Buy
2,517
+490
+24% +$14.6K ﹤0.01% 1584
2024
Q1
$104K Hold
2,027
﹤0.01% 1499
2023
Q4
$143K Hold
2,027
﹤0.01% 1455
2023
Q3
$149K Hold
2,027
﹤0.01% 1448
2023
Q2
$303K Hold
2,027
﹤0.01% 1248
2023
Q1
$107K Buy
2,027
+554
+38% +$33.3K ﹤0.01% 1490
2022
Q4
$135K Buy
1,473
+1,007
+216% +$218K ﹤0.01% 1439
2022
Q3
$108K Hold
466
﹤0.01% 1498
2022
Q2
$87K Sell
466
-150
-24% -$41.8K ﹤0.01% 1558
2022
Q1
$241K Buy
616
+36
+6% +$10.8K ﹤0.01% 1448
2021
Q4
$204K Buy
+580
New +$277K ﹤0.01% 1566

Other funds holding PIII

William Blair & Company's PIII Position: Q1 2026 in Review

William Blair & Company held its P3 Health Partners (PIII) position steady in Q1 2026 at 3,092 shares worth $9.52K. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

William Blair & Company first reported a position in PIII in Q4 2021 and has held it in 17 quarters since. The position peaked at $303K in Q2 2023. 17 funds tracked by Wall St. Rank hold PIII as of Q1 2026.

  • William Blair & Company held 3,092 shares of P3 Health Partners worth $9.52K as of Q1 2026.
  • William Blair & Company left its P3 Health Partners share count unchanged in Q1 2026.
  • P3 Health Partners made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1834 holding.
  • William Blair & Company first reported a position in P3 Health Partners in Q4 2021 and has held it in 17 quarters since.
  • William Blair & Company's P3 Health Partners position peaked at $303K in Q2 2023.
  • 17 funds tracked by Wall St. Rank held P3 Health Partners as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.